All News

Petros Grivas, MD, PhD, on Updates in Genitourinary Oncology From ASCO 2021
June 20, 2021

Petros Grivas, MD, PhD, regarding updates in genitourinary oncology that were read out at the meeting.

Phase 1/2 Trial of Frontline Eprenetapopt Plus Venetoclax and Azacitidine for TP53-Mutant AML Meets End Point
June 20, 2021

A trial of an eprenetapopt combination has met the prespecified primary efficacy end point in patients with acute myeloid leukemia harboring TP53 mutations.

Longer Follow-Up Shows Cilta-Cel Induces Deep, Durable Responses in Relapsed/Refractory MM
June 19, 2021

At the 18-month follow-up, the CAR T-cell therapy led to early, deep, and durable responses with a manageable safety profile in patients with relapsed/refractory multiple myeloma.